Joel Pomerantz, recipient of the Lee Hood Prize in Biomedical Science!
Dr. Pomerantz’s research is focused on cell signaling pathways in the immune system. At Johns Hopkins, Dr. Pomerantz has focused on CARD11, a protein that acts as a hub for signals that link antigen engagement at the cell surface with control of gene expression in the nucleus. His work has revealed how CARD11 functions and how oncogenic mutations in CARD11 contribute to a subset of lymphomas. Motivated by his dissection of immune signaling pathways, Dr. Pomerantz has developed innovative technologies for genetic screens in mammalian tissue culture cells.